A prospective cohort study reported that the National Institute of Health Stroke Scale scores of high Hcy level group were significantly higher than those of low level group in 194 acute ischemic stroke patients after 1-week tissue plasminogen activator treatment. The gene discussed is PLAT; the disease is stroke disorder.